News Sanofi’s dermatitis drug dupilumab fast-tracked by FDA Drug could earn $2.8 billion if approved in AD and asthma
Views & Analysis Digital Health Round-up – Verily's diabetes ambitions; IBM W... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
Views & Analysis Google alliance Onduo central to Sanofi’s diabetes revival How will Onduo help Sanofi revive its diabetes business?
News GSK/Janssen's rheumatoid arthritis drug filed in EU Drug could compete against Sanofi rival if approved.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
